vs

Side-by-side financial comparison of Arcellx, Inc. (ACLX) and Citizens Community Bancorp Inc. (CZWI). Click either name above to swap in a different company.

Citizens Community Bancorp Inc. is the larger business by last-quarter revenue ($15.8M vs $8.1M, roughly 1.9× Arcellx, Inc.). Citizens Community Bancorp Inc. runs the higher net margin — 27.1% vs -766.0%, a 793.1% gap on every dollar of revenue. On growth, Citizens Community Bancorp Inc. posted the faster year-over-year revenue change (14.9% vs -79.3%). Citizens Community Bancorp Inc. produced more free cash flow last quarter ($10.4M vs $-63.9M). Over the past eight quarters, Citizens Community Bancorp Inc.'s revenue compounded faster (1.9% CAGR vs -24.6%).

Arcellx, Inc. is a clinical-stage biotechnology company that develops innovative chimeric antigen receptor T (CAR-T) cell therapies for treating hard-to-treat cancers including hematologic malignancies and solid tumors. Its core pipeline targets unmet oncology medical needs, serving global patient populations and partnering with life sciences stakeholders.

Glacier Bancorp, Inc. is a regional multi-bank holding company headquartered in Kalispell, Montana, United States. It is a successor corporation to the Delaware corporation originally incorporated in 1990. The company provides personal and commercial banking services from 221 locations in Montana, Idaho, Utah, Washington, Wyoming, Colorado, Arizona, and, Nevada.

ACLX vs CZWI — Head-to-Head

Bigger by revenue
CZWI
CZWI
1.9× larger
CZWI
$15.8M
$8.1M
ACLX
Growing faster (revenue YoY)
CZWI
CZWI
+94.2% gap
CZWI
14.9%
-79.3%
ACLX
Higher net margin
CZWI
CZWI
793.1% more per $
CZWI
27.1%
-766.0%
ACLX
More free cash flow
CZWI
CZWI
$74.3M more FCF
CZWI
$10.4M
$-63.9M
ACLX
Faster 2-yr revenue CAGR
CZWI
CZWI
Annualised
CZWI
1.9%
-24.6%
ACLX

Income Statement — Q1 FY2025 vs Q4 FY2025

Metric
ACLX
ACLX
CZWI
CZWI
Revenue
$8.1M
$15.8M
Net Profit
$-62.3M
$4.3M
Gross Margin
Operating Margin
-847.6%
31.0%
Net Margin
-766.0%
27.1%
Revenue YoY
-79.3%
14.9%
Net Profit YoY
-765.1%
58.1%
EPS (diluted)
$-1.13
$0.44

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ACLX
ACLX
CZWI
CZWI
Q4 25
$15.8M
Q3 25
$16.2M
Q2 25
$16.1M
Q1 25
$8.1M
$14.2M
Q4 24
$15.3M
$13.7M
Q3 24
$26.0M
$14.2M
Q2 24
$27.4M
$13.5M
Q1 24
$39.3M
$15.2M
Net Profit
ACLX
ACLX
CZWI
CZWI
Q4 25
$4.3M
Q3 25
$3.7M
Q2 25
$3.3M
Q1 25
$-62.3M
$3.2M
Q4 24
$-47.1M
$2.7M
Q3 24
$-25.9M
$3.3M
Q2 24
$-27.2M
$3.7M
Q1 24
$-7.2M
$4.1M
Operating Margin
ACLX
ACLX
CZWI
CZWI
Q4 25
31.0%
Q3 25
27.9%
Q2 25
25.1%
Q1 25
-847.6%
28.0%
Q4 24
-348.2%
24.5%
Q3 24
-129.1%
29.5%
Q2 24
-127.8%
35.0%
Q1 24
-40.3%
34.2%
Net Margin
ACLX
ACLX
CZWI
CZWI
Q4 25
27.1%
Q3 25
22.7%
Q2 25
20.3%
Q1 25
-766.0%
22.5%
Q4 24
-308.4%
19.7%
Q3 24
-99.4%
23.1%
Q2 24
-99.3%
27.2%
Q1 24
-18.3%
26.9%
EPS (diluted)
ACLX
ACLX
CZWI
CZWI
Q4 25
$0.44
Q3 25
$0.37
Q2 25
$0.33
Q1 25
$-1.13
$0.32
Q4 24
$-0.87
$0.28
Q3 24
$-0.48
$0.32
Q2 24
$-0.51
$0.35
Q1 24
$-0.14
$0.39

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ACLX
ACLX
CZWI
CZWI
Cash + ST InvestmentsLiquidity on hand
$543.3M
$118.9M
Total DebtLower is stronger
$51.8M
Stockholders' EquityBook value
$416.9M
$187.9M
Total Assets
$648.1M
$1.8B
Debt / EquityLower = less leverage
0.28×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ACLX
ACLX
CZWI
CZWI
Q4 25
$118.9M
Q3 25
$82.4M
Q2 25
$67.5M
Q1 25
$543.3M
$100.2M
Q4 24
$587.4M
$50.2M
Q3 24
$574.3M
$36.6M
Q2 24
$516.7M
$36.9M
Q1 24
$573.9M
$28.6M
Total Debt
ACLX
ACLX
CZWI
CZWI
Q4 25
$51.8M
Q3 25
Q2 25
Q1 25
Q4 24
$66.6M
Q3 24
Q2 24
Q1 24
Stockholders' Equity
ACLX
ACLX
CZWI
CZWI
Q4 25
$187.9M
Q3 25
$186.8M
Q2 25
$183.5M
Q1 25
$416.9M
$180.1M
Q4 24
$454.8M
$179.1M
Q3 24
$483.0M
$180.1M
Q2 24
$487.2M
$176.0M
Q1 24
$496.6M
$172.8M
Total Assets
ACLX
ACLX
CZWI
CZWI
Q4 25
$1.8B
Q3 25
$1.7B
Q2 25
$1.7B
Q1 25
$648.1M
$1.8B
Q4 24
$711.3M
$1.7B
Q3 24
$764.9M
$1.8B
Q2 24
$734.3M
$1.8B
Q1 24
$779.7M
$1.8B
Debt / Equity
ACLX
ACLX
CZWI
CZWI
Q4 25
0.28×
Q3 25
Q2 25
Q1 25
Q4 24
0.37×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ACLX
ACLX
CZWI
CZWI
Operating Cash FlowLast quarter
$-63.1M
$11.7M
Free Cash FlowOCF − Capex
$-63.9M
$10.4M
FCF MarginFCF / Revenue
-786.4%
65.9%
Capex IntensityCapex / Revenue
9.6%
8.3%
Cash ConversionOCF / Net Profit
2.74×
TTM Free Cash FlowTrailing 4 quarters
$-122.5M
$17.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ACLX
ACLX
CZWI
CZWI
Q4 25
$11.7M
Q3 25
$6.6M
Q2 25
$-406.0K
Q1 25
$-63.1M
$1.6M
Q4 24
$-46.0M
$20.4M
Q3 24
$30.7M
$3.5M
Q2 24
$-36.2M
$5.1M
Q1 24
$-31.9M
$9.1M
Free Cash Flow
ACLX
ACLX
CZWI
CZWI
Q4 25
$10.4M
Q3 25
$6.2M
Q2 25
$-632.0K
Q1 25
$-63.9M
$1.5M
Q4 24
$-47.5M
$19.5M
Q3 24
$28.4M
$3.4M
Q2 24
$-39.5M
$4.8M
Q1 24
$-38.3M
$8.9M
FCF Margin
ACLX
ACLX
CZWI
CZWI
Q4 25
65.9%
Q3 25
38.4%
Q2 25
-3.9%
Q1 25
-786.4%
10.7%
Q4 24
-311.3%
142.2%
Q3 24
109.2%
23.8%
Q2 24
-144.1%
35.7%
Q1 24
-97.7%
58.9%
Capex Intensity
ACLX
ACLX
CZWI
CZWI
Q4 25
8.3%
Q3 25
2.4%
Q2 25
1.4%
Q1 25
9.6%
0.7%
Q4 24
9.8%
6.5%
Q3 24
8.8%
0.9%
Q2 24
11.7%
2.3%
Q1 24
16.4%
1.4%
Cash Conversion
ACLX
ACLX
CZWI
CZWI
Q4 25
2.74×
Q3 25
1.80×
Q2 25
-0.12×
Q1 25
0.50×
Q4 24
7.55×
Q3 24
1.07×
Q2 24
1.39×
Q1 24
2.24×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons